Advertisement

Depletion of Kininogen I by Stem Bromelain and Its Significance Prevention of Adrenalin-Induced Pulmonary Edema in Rats

  • Makoto Katori
  • Satoru Mineshita
  • Tatsuro Shigei
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 8)

Abstract

It was found in this laboratory that an intravenous injection of stem bromelain (BRM) prevented the adrenaline-induced pulmonary edema in rats, while an injection of papain (PAP) did not, in spite of the fact that both enzymes are thiol-proteases from the plant origin (Shigei et al., 1967). In addition, the preventive effect of BRM was due to the proteolytic activity of the enzyme, because both the caseinolytic and the edema-preventing activities were abolished after incubation of the enzyme with a SH inhibitor, N-ethyl-maleimide (Enomoto et al., 1968).

Keywords

Pulmonary Edema Incubation Mixture Organ Bath Plasma Kallikrein Kinin System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. AMUNDSEN, E. and NUSTAD, K. (1964). Nature, Lond., 201, 1226–1227.CrossRefGoogle Scholar
  2. DI MATTEI, P. (1962). Arch. int. Pharmacodyn. l40, 368–373.Google Scholar
  3. ENOMOTO, T., MINESHITA, S., OH-ISHI, S. and SHIGEI, T. (1967). Jap. J. Pharmac. 17, 332–333.CrossRefGoogle Scholar
  4. ENOMOTO, T., MINESHITA, S. and SHIGEI, T. (1968). Jap. J. Pharmac. 18, 260–265.CrossRefGoogle Scholar
  5. GAUTVIK, K. M. and RUGSTAD, H. E. (1967). Brit.J.Pharmac.Chemother. 31, 390–400.Google Scholar
  6. HENRIQUES, O. B., KAURITCHEVE, N., KUZNETSOVA, V. and ASTRAKAN, M. (1967). Nature, Lond., 215, 1200–1201.CrossRefGoogle Scholar
  7. JACOBSEN, S. (1966 a). Brit. J. Pharmac. Chemother. 26, 403–411.Google Scholar
  8. JACOBSEN, S. (1966 b). Brit. J. Pharmac. Chemother. 28, 64–72.Google Scholar
  9. KATORI, M. and SHIGEI, T. (1968). Jap. J. Pharmac. 28, 277–279.CrossRefGoogle Scholar
  10. LEME, J. G., SCHAPOVAL, E. E. S. and ROCHA E. SILVA, M. (1966). In International Symposium on Vaso-active Polypeptides;Bradykinin and Related Kinins.(ed. Rocha e Silva, M.) p.213–221, Ribeirao Preto, S. P.Google Scholar
  11. NAGASAWA, S., TAKAHASHI, H., KOIDA, M., SUZUKI, T. and SCHOENMAKERS, J. G. G. (1968). Biochem. biophys. Res. Commun. 32, 644–649.PubMedCrossRefGoogle Scholar
  12. PIERCE, J. V. and WEBSTER, M. E. (1966). In Hypotensive Peptides, (ed. Erdos, E. G., Back, N., Sicuteri, F. and Wilde, A. F.) p.130–138, Springer-Verlag, N. Y.CrossRefGoogle Scholar
  13. ROTHSCHILD, A. M. and CASTANIA, A. (1968 a). J. Pharm. Pharmac. 20, 77–78.CrossRefGoogle Scholar
  14. ROTHSCHILD, A. M. (1968 b). Brit. J. Pharmac. Chemother. 33, 501– 512.Google Scholar
  15. SHIGEI, T., SAKUMA, A., ENOMOTO, T., OH-ISHI, S. and HATANO, R. (1967). Jap. J. Pharmac. 17, 591–602.CrossRefGoogle Scholar
  16. YANO, M., NAGASAWA, S., HORIUCHI, K. and SUZUKI, T. (1967). J. Biochem. 62, 504–506.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1970

Authors and Affiliations

  • Makoto Katori
    • 1
  • Satoru Mineshita
    • 1
  • Tatsuro Shigei
    • 1
  1. 1.Department of Pharmacology, Institute for Cardiovascular DiseasesTokyo Medical and Dental UniversityJapan

Personalised recommendations